GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

December 15, 2023

https://www.globenewswire.com/news-release/2023/12/01/2789292/0/en/GeneDx-Presents-New-Data-at-the-American-Epilepsy-Society-Annual-Meeting-Demonstrating-That-Exome-Sequencing-Outperforms-Multi-Gene-Panels-for-Patients-with-Epilepsy.html

STAMFORD, Conn., Dec. 01, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq:WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced new data to be presented at the American Epilepsy Society (AES) annual meeting in Orlando, Florida, December 1-5, 2023, that supports the use of exome sequencing as a first-tier test for patients with epilepsy.

Read more at globenewswire.com

Related news for (WGS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.